Drug Discovery Product Showcase

31. Assess the Safety Profile Of Pharmaceutical Impurities 6/3/2026

    Predict Genotoxic & Carcinogenic Endpoints to Meet ICH M7(R2) Guidelines

    ACD/Impurity Profiling Suite predicts a variety of toxicological endpoints to help you assess the genotoxic and carcinogenic potential of impurities and degradants. Developed through a collaborative agreement with the US Food and Drug Administration (FDA), the software can be used as part of your ICH M7(R2) workflow—to help prepare regulatory submissions and remain compliant.

    • Determine the ICH M7(R2) classification for impurities and degradants
    • Predict 21 toxicological endpoints from structure; for mechanisms of hazardous activity including:
      • Mutagenicity (AMES test and other procaryote and eucaryote test systems)
      • Clastogenicity
      • Other DNA damage
      • Carcinogenicity
      • Endocrine disruption mechanisms
    • Identify potentially hazardous structural fragments responsible for carcinogenic and genotoxic activity
    • Gain insight into the possible mechanisms of toxic effects
    • Assess the reliability of predictions
32. Software For Efficient, Comprehensive Metabolite Identification 6/3/2026

    Accelerate metabolite identification with integrated analytics, predictive modeling, and automated data extraction. Visualize pathways, kinetics, and spectra in one place to improve confidence.

33. Streamline Experiments From Design To Decide 6/3/2026

    Gain insight into how a connected approach to experimental design and data management helps reduce errors, accelerate iteration cycles, and unlock deeper insights.

34. Assess The Safety Of Pharmaceutical Impurities In Silico 6/3/2026

    Advance impurity risk assessment with predictive modeling that clarifies toxicity mechanisms, strengthens regulatory arguments, and reduces experimental burden—helping teams make confident decisions.

35. Manage And Share Analytical Data With Context 6/3/2026

    Disconnected analytical data slows discovery and limits insight. Take a look at how a unified, searchable environment brings structure, context, and automation to complex datasets.

36. Automate Method Development And Achieve QbD 6/3/2026

    Learn about a smarter, data-driven path to chromatographic method development that reduces experimentation, predicts optimal conditions, and improves robustness—all while shortening timelines.

37. Develop Chromatographic Methods In Less Time 6/3/2026

    ACD/AutoChrom helps experts develop chromatographic separations using QbD principles. It uses a workflow-based structure to streamline and track a project so you can:

    • Begin with reasonable starting conditions and columns
    • Define a strategy and implement it with help from software wizards and assistants
    • Automatically run experiments for screening and optimization
    • Model your separation in 1D, 2D, or 3D
    • Document the reasons for your decisions and database your projects for future learning
38. Calculate Abraham Solvation Parameters 6/3/2026

    Calculate Abraham Solvation Parameters and various solvation-related properties of solutes, directly from structure.

    Use ACD/Absolv to:

    • Predict solvation parameters A, B, B_O, E, S, L, and V
    • Calculate various solvent-solvent or gas-solvent partition coefficients
    • Visualize the contributions of each atom in the structure to each Abraham solvation parameter
    • Assess the relevance of the result
    • Access a database of Abraham coefficients for >5000 compounds
39. Assay Development And Screening 5/28/2026

    We deliver custom assay development, screening, potency, and selectivity testing services for the pharmaceutical, biopharmaceutical, and agrochemical industries.

40. Cell-Based Assay Development And Testing 5/28/2026

    Evaluating small and large molecule therapeutics within cellular environments is essential to understanding their efficacy, potency, and safety within a complex biological system.